These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
329 related articles for article (PubMed ID: 16611037)
1. Epidemiology of Candida albicans infections and role of non-Candida-albicans yeasts. Ruhnke M Curr Drug Targets; 2006 Apr; 7(4):495-504. PubMed ID: 16611037 [TBL] [Abstract][Full Text] [Related]
2. Candida and candidaemia. Susceptibility and epidemiology. Arendrup MC Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246 [TBL] [Abstract][Full Text] [Related]
3. Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia. Shorr AF; Lazarus DR; Sherner JH; Jackson WL; Morrel M; Fraser VJ; Kollef MH Crit Care Med; 2007 Apr; 35(4):1077-83. PubMed ID: 17312565 [TBL] [Abstract][Full Text] [Related]
4. [Prevalence of Candida albicans and Candida non-albicans in clinical samples during 1999-2001]. Mujica MT; Finquelievich JL; Jewtuchowicz V; Iovannitti CA Rev Argent Microbiol; 2004; 36(3):107-12. PubMed ID: 15559191 [TBL] [Abstract][Full Text] [Related]
5. Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp. Playford EG; Marriott D; Nguyen Q; Chen S; Ellis D; Slavin M; Sorrell TC Crit Care Med; 2008 Jul; 36(7):2034-9. PubMed ID: 18552700 [TBL] [Abstract][Full Text] [Related]
7. The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer. Bodey GP; Mardani M; Hanna HA; Boktour M; Abbas J; Girgawy E; Hachem RY; Kontoyiannis DP; Raad II Am J Med; 2002 Apr; 112(5):380-5. PubMed ID: 11904112 [TBL] [Abstract][Full Text] [Related]
8. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Nguyen MH; Peacock JE; Morris AJ; Tanner DC; Nguyen ML; Snydman DR; Wagener MM; Rinaldi MG; Yu VL Am J Med; 1996 Jun; 100(6):617-23. PubMed ID: 8678081 [TBL] [Abstract][Full Text] [Related]
9. Neonatal candidiasis: analysis of epidemiology, drug susceptibility, and molecular typing of causative isolates. Roilides E; Farmaki E; Evdoridou J; Dotis J; Hatziioannidis E; Tsivitanidou M; Bibashi E; Filioti I; Sofianou D; Gil-Lamaignere C; Mueller FM; Kremenopoulos G Eur J Clin Microbiol Infect Dis; 2004 Oct; 23(10):745-50. PubMed ID: 15605181 [TBL] [Abstract][Full Text] [Related]
10. Relationship of fluconazole prophylaxis with fungal microbiology in hospitalized intra-abdominal surgery patients: a descriptive cohort study. Zilberberg M; Yu HT; Chaudhari P; Emons MF; Khandelwal N; Shorr AF Crit Care; 2014 Oct; 18(5):590. PubMed ID: 25358521 [TBL] [Abstract][Full Text] [Related]
11. Candida glabrata among Candida spp. from environmental health practitioners of a Brazilian Hospital. Savastano C; de Oliveira Silva E; Gonçalves LL; Nery JM; Silva NC; Dias AL Braz J Microbiol; 2016; 47(2):367-72. PubMed ID: 26991302 [TBL] [Abstract][Full Text] [Related]
12. Emergence of non-Candida albicans species: Epidemiology, phylogeny and fluconazole susceptibility profile. Sadeghi G; Ebrahimi-Rad M; Mousavi SF; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M J Mycol Med; 2018 Mar; 28(1):51-58. PubMed ID: 29366545 [TBL] [Abstract][Full Text] [Related]
13. Seven-year trend analysis of nosocomial candidemia and antifungal (fluconazole and caspofungin) use in Intensive Care Units at a Brazilian University Hospital. Girão E; Levin AS; Basso M; Gobara S; Gomes LB; Medeiros EA; Costa SF Med Mycol; 2008 Sep; 46(6):581-8. PubMed ID: 19180727 [TBL] [Abstract][Full Text] [Related]
14. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains. Panizo MM; Reviákina V; Dolande M; Selgrad S Med Mycol; 2009 Mar; 47(2):137-43. PubMed ID: 18651308 [TBL] [Abstract][Full Text] [Related]
15. Epidemiology of candidemia and antifungal susceptibility in invasive Candida species in the Asia-Pacific region. Wang H; Xu YC; Hsueh PR Future Microbiol; 2016 Oct; 11():1461-1477. PubMed ID: 27750452 [TBL] [Abstract][Full Text] [Related]
16. The increased role of non-albicans species in candidaemia: results from a 3-year surveillance study. Tan TY; Tan AL; Tee NW; Ng LS; Chee CW Mycoses; 2010 Nov; 53(6):515-21. PubMed ID: 19619263 [TBL] [Abstract][Full Text] [Related]
17. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006). Leroy O; Gangneux JP; Montravers P; Mira JP; Gouin F; Sollet JP; Carlet J; Reynes J; Rosenheim M; Regnier B; Lortholary O; Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476 [TBL] [Abstract][Full Text] [Related]
18. New options for treatment of candidaemia in critically ill patients. Ruhnke M; Hartwig K; Kofla G Clin Microbiol Infect; 2008 May; 14 Suppl 4():46-54. PubMed ID: 18430129 [TBL] [Abstract][Full Text] [Related]
19. [Changing epidemiological aspects of candidemia and their clinical and therapeutic implications]. Salavert Lletí M; Jarque Ramos I; Pemán García J Enferm Infecc Microbiol Clin; 2006 Oct; 24 Suppl 1():36-45. PubMed ID: 17125667 [TBL] [Abstract][Full Text] [Related]